Waning Humoral Response 3 to 6 Months after Vaccination with the SARS-COV-2 BNT162b2 mRNA Vaccine in Dialysis Patients

Background and objectives: The short-term reported antibody response to SARS-COV-2 vaccination in dialysis patients is high, with a seroconversion response rate up to 97%. Data on the long-term durability of this response are scarce. Our objective was to characterize the long-term anti-spike antibod...

Descripción completa

Detalles Bibliográficos
Autores principales: Berar-Yanay, Noa, Freiman, Sarit, Shapira, Maʹanit, Saffoury, Amer, Elemy, Ameer, Hamze, Munir, Elhaj, Mohamad, Zaher, Maha, Matanis, Loai, Armaly, Zaher Anis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745040/
https://www.ncbi.nlm.nih.gov/pubmed/35011801
http://dx.doi.org/10.3390/jcm11010064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745040/
https://www.ncbi.nlm.nih.gov/pubmed/35011801
http://dx.doi.org/10.3390/jcm11010064

Ejemplares similares